phone: +48 22 721 40 00   /  fax: +48 22 721 13 33  /   bioinfo@bioton.pl



Bioton



Current reports

 

Current report (24/2019) dated 07.09.2019, time 12:27 UTC

Warsaw, 7 September 2019

Termination of the agreement for the commercialization of recombinant human insulin in the territory of Brazil.

read more 


Current report (23/2019) dated 04.09.2019, time 10:59 UTC

Warsaw, 4 September 2019

Disclosure of delayed information – start of negotiations related to the extension of the loan repayment date with relation to potential transaction proposed by Dongren capital group involving the sale of the Company’s shares.

read more 


Current report (22/2019) dated 29.08.2019, time 13:31 UTC

Warsaw, 29 August 2019

Correction of the periodic report and consolidated periodic report for 2018

read more 


 

Current report (21/2019) dated 29.08.2019, time 11:53 UTC

Warsaw, 29 August 2019

Disclosure of ownership

read more 


© 2019 BIOTON S.A.